Altimmune, Inc.ALTNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank71
Studio
Year-over-Year Change

Return on equity

Latest
-39.17%
↓ 179% vs avg
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
49.68%
Historical baseline
PeriodValueYoY Change
2025-39.17%+49.1%
2024-76.97%-68.9%
2023-45.57%+0.3%
2022-45.72%+6.2%
2021-48.76%-124.5%
2020-21.71%+51.8%
2019-45.08%+44.4%
2018-81.08%+15.0%
2017-95.37%-109.6%
2016996.21%-